Open AccessSafety and Effectiveness of a Novel Neuroprotectant, KUS121, in Patients with Non-Arteritic Central Retinal Artery Occlusion: An Open-Label, Non-Randomized, First-in-Humans Phase 1/2 Trial
Author(s) -
Hanako Ohashi Ikeda,
Yuki Muraoka,
Masayuki Hata,
Eriko Sumi,
Takafumi Ikeda,
Takayuki Nakagawa,
Hiroyasu Abe,
Harue Tada,
Satoshi Morita,
Akira Kakizuka,
Nagahisa Yoshimura,
Akitaka Tsujikawa
Publication year - 2018
Publication title -
ssrn electronic journal
Language(s) - English
Resource type - Journals
ISSN - 1556-5068
DOI - 10.2139/ssrn.3299127
Subject(s) - central retinal artery occlusion , medicine , randomized controlled trial , open label , central retinal artery , occlusion , retinal , central retinal vein occlusion , physical medicine and rehabilitation , ophthalmology , anesthesia , cardiology , surgery , macular edema
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom